Physician profile
Christopher L Marquart
NPI 1790728798
$3,135.57
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,014 · 2020: $894 · 2021: $711 · 2022: $356 · 2023: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $570.77 | 2019-2023 | Mavenclad |
| Boston Scientific Corporation | $293.73 | 2019-2020 | |
| Irras USA, INC. | $207.99 | 2019 | |
| Lundbeck LLC | $136.51 | 2020-2022 | |
| Amgen INC. | $130.00 | 2019-2021 | |
| Genzyme Corporation | $109.76 | 2019-2020 | |
| Ucb, INC. | $102.46 | 2019-2021 | |
| Djo, LLC | $100.00 | 2019-2020 | |
| Abbvie INC. | $95.68 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $88.74 | 2021-2023 | Austedo |
| Janssen Pharmaceuticals, INC | $87.50 | 2020-2021 | |
| Eisai INC. | $84.20 | 2019-2022 | |
| Depuy Synthes Sales INC. | $83.51 | 2020 | |
| Greenwich Biosciences, INC. | $83.43 | 2021 | |
| Alexion Pharmaceuticals, INC. | $82.70 | 2019-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $77.85 | 2019 | |
| Celgene Corporation | $73.83 | 2021-2023 | |
| Pfizer INC. | $68.73 | 2019-2023 | |
| Mdd US Operations, LLC | $58.99 | 2019-2021 | |
| Upsher-Smith Laboratories LLC | $58.33 | 2020-2023 | |
| Allergan, INC. | $55.23 | 2022 | |
| Neurelis, INC. | $54.11 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $51.09 | 2020 | |
| Surgalign Spine Technologies, INC. | $44.38 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $38.02 | 2019 | |
| Nevro Corp. | $37.84 | 2019 | |
| Integra Lifesciences Corporation | $35.09 | 2019-2022 | |
| Kyowa Kirin, INC. | $33.26 | 2021 | |
| Abbott Laboratories | $29.09 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $28.59 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $23.78 | 2022 | |
| Avanir Pharmaceuticals, INC. | $22.05 | 2019 | |
| Impel Pharmaceuticals INC. | $21.89 | 2022 | |
| Medtronic USA, INC. | $18.84 | 2019 | |
| Medtronic, INC. | $17.61 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.41 | 2019 | |
| Csl Behring | $14.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Marquart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.